Trial NCT04494984
Publication Lopardo G, SSRN, 2021
Primary outcome on the report: Proportion of patients that showed improvement 28 days after the administration of the first dose of at least two categories based upon the WHO ordinal clinical status scale or hospital discharge

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.